NCT02049320View on ClinicalTrials.gov

Remifentanil for Sedation of Patients With Traumatic Brain Injury (TBI)

CompletedOBSERVATIONAL
Enrollment

38

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

May 31, 2016

Study Completion Date

May 31, 2016

Conditions
Traumatic Brain Injury
Interventions
DRUG

Remifentanil

Trial Locations (1)

43205

Nationwide Children's Hospital, Columbus

All Listed Sponsors
lead

Joseph D. Tobias

OTHER

NCT02049320 - Remifentanil for Sedation of Patients With Traumatic Brain Injury (TBI) | Biotech Hunter | Biotech Hunter